Israel Englander Immuneering Corp Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Immuneering Corp stock. As of the latest transaction made, Millennium Management LLC holds 953,226 shares of IMRX stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
953,226
Previous 63,262
1406.79%
Holding current value
$2.54 Million
Previous $182,000
570.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMRX
# of Institutions
60Shares Held
9.65MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.88MShares$5.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.85 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD859KShares$2.29 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY742KShares$1.97 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX550KShares$1.46 Million0.22% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $70.2M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...